chr3-148844522-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_StrongBP6_ModerateBP7
The NM_001871.3(CPB1):c.621C>T(p.Leu207Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000268 in 1,613,882 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
Genomes: 𝑓 0.0015 ( 1 hom., cov: 32)
Exomes 𝑓: 0.00014 ( 1 hom. )
Consequence
CPB1
NM_001871.3 synonymous
NM_001871.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -3.00
Genes affected
CPB1 (HGNC:2299): (carboxypeptidase B1) Three different procarboxypeptidases A and two different procarboxypeptidases B have been isolated. The B1 and B2 forms differ from each other mainly in isoelectric point. Carboxypeptidase B1 is a highly tissue-specific protein and is a useful serum marker for acute pancreatitis and dysfunction of pancreatic transplants. It is not elevated in pancreatic carcinoma. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 3-148844522-C-T is Benign according to our data. Variant chr3-148844522-C-T is described in ClinVar as [Benign]. Clinvar id is 784026.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-3 with no splicing effect.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPB1 | ENST00000282957.9 | c.621C>T | p.Leu207Leu | synonymous_variant | 7/11 | 1 | NM_001871.3 | ENSP00000282957.4 | ||
CPB1 | ENST00000491148.5 | c.621C>T | p.Leu207Leu | synonymous_variant | 8/12 | 5 | ENSP00000417222.1 | |||
CPB1 | ENST00000468341.1 | c.519C>T | p.Leu173Leu | synonymous_variant | 6/7 | 3 | ENSP00000419427.1 | |||
CPB1 | ENST00000484877.1 | n.*26C>T | downstream_gene_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.00147 AC: 224AN: 152138Hom.: 1 Cov.: 32
GnomAD3 genomes
AF:
AC:
224
AN:
152138
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000354 AC: 89AN: 251090Hom.: 0 AF XY: 0.000184 AC XY: 25AN XY: 135692
GnomAD3 exomes
AF:
AC:
89
AN:
251090
Hom.:
AF XY:
AC XY:
25
AN XY:
135692
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000142 AC: 207AN: 1461626Hom.: 1 Cov.: 30 AF XY: 0.000132 AC XY: 96AN XY: 727110
GnomAD4 exome
AF:
AC:
207
AN:
1461626
Hom.:
Cov.:
30
AF XY:
AC XY:
96
AN XY:
727110
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00148 AC: 226AN: 152256Hom.: 1 Cov.: 32 AF XY: 0.00148 AC XY: 110AN XY: 74450
GnomAD4 genome
AF:
AC:
226
AN:
152256
Hom.:
Cov.:
32
AF XY:
AC XY:
110
AN XY:
74450
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
CPB1-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jun 11, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 20, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at